• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery - Product Image

New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

  • ID: 2259008
  • September 2012
  • Region: New Zealand
  • 91 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • Apex Biotechnology C
  • Bayer HealthCare AG
  • F. Hoffmann-La Roche Ltd.
  • Medtronic, Inc.
  • Sanofi
  • MORE

New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

Summary

Our new report, “New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery” provides key market data on the New Zealand Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) READ MORE >

FEATURED COMPANIES

  • Abbott Laboratories
  • Apex Biotechnology C
  • Bayer HealthCare AG
  • F. Hoffmann-La Roche Ltd.
  • Medtronic, Inc.
  • Sanofi
  • MORE

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Diabetes Care Devices In New Zealand
3.1 Diabetes Care Devices, Market Segmentation
3.2 Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018
3.3 Diabetes Care Devices Market, New Zealand, Revenue Mix ($m), 2011
3.4 Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2011
3.5 Diabetes Care Devices, New Zealand, Company Share (2010-2011)
4 Glucose Monitoring In New Zealand
4.1 Glucose Monitoring, Market Segmentation
4.2 Glucose Monitoring Market, New Zealand, Revenue Mix ($m), 2011
4.3 Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2011
4.4 Glucose Monitoring Overall Revenue, (2004-2018)
4.4.1 Blood Glucose Meters, Revenue (2004-2018)
4.5 Glucose Monitoring Overall Volume (2004-2018)
4.5.1 Blood Glucose Meters, Volume (2004-2018)
4.6 Glucose Monitoring Average Price (2004-2018)
4.7 Glucose Monitoring Distribution Share (2010-2011)
4.8 Glucose Monitoring, New Zealand, Company Share (2010-2011)
5 Insulin Delivery In New Zealand
5.1 Insulin Delivery, Market Segmentation
5.2 Insulin Delivery Market, New Zealand, Revenue Mix ($m), 2011
5.3 Insulin Delivery Market, New Zealand, Segment Contribution (%), 2011
5.4 Insulin Delivery Overall Revenue, (2004-2018)
5.4.1 Insulin Pens, Revenue (2004-2018)
5.4.2 Insulin Pumps, Revenue (2004-2018)
5.5 Insulin Delivery Overall Volume (2004-2018)
5.5.1 Insulin Pens, Volume (2004-2018)
5.5.2 Insulin Pumps, Volume (2004-2018)
5.6 Insulin Delivery Average Price (2004-2018)
5.7 Insulin Delivery Distribution Share (2010-2011)
5.8 Insulin Delivery, New Zealand, Company Share (2010-2011)
6 Overview of Key Companies in New Zealand Diabetes Care Devices Market
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Share in the New Zealand Diabetes Care Devices Market
6.2 Abbott Laboratories
6.2.1 Company Overview
6.2.2 Share in the New Zealand Diabetes Care Devices Market
6.3 Bayer HealthCare AG
6.3.1 Company Overview
6.3.2 Share in the New Zealand Diabetes Care Devices Market
6.4 Novo Nordisk A/S
6.4.1 Company Overview
6.4.2 Share in the New Zealand Diabetes Care Devices Market
6.5 ARKRAY, Inc.
6.5.1 Company Overview
6.5.2 Share in the New Zealand Diabetes Care Devices Market
6.6 Animas Corporation
6.6.1 Company Overview
6.6.2 Share in the New Zealand Diabetes Care Devices Market
6.7 Eli Lilly and Company
6.7.1 Company Overview
6.8 LifeScan, Inc.
6.8.1 Company Overview
6.9 Medtronic, Inc.
6.9.1 Company Overview
6.10 Becton, Dickinson and Company
6.10.1 Company Overview
6.11 Sanofi
6.11.1 Company Overview
6.12 Terumo Corporation
6.12.1 Company Overview
6.13 Apex Biotechnology Corp.
6.13.1 Company Overview
6.14 Nipro Corporation
6.14.1 Company Overview
7 Diabetes Care Devices Market Pipeline Products
8 Appendix
8.1 Definitions of Markets Covered in the Report
8.1.1 Diabetes Care Devices
8.2 Research Methodology
8.3 Secondary Research
8.4 Primary Research
8.5 Models
8.6 Forecasts
8.7 Expert Panels
8.8 Consulting
8.9 Currency Conversion
8.10 Contact Us
8.11 Disclaimer

1.1 List of Tables
Table 1: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2011
Table 3: Diabetes Care Devices, New Zealand, Cross-Segment Analysis, 2004-2018
Table 4: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: Diabetes Care Devices, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 7: Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2011
Table 8: Glucose Monitoring, New Zealand, Revenue ($m-) USD Constant, by Segment, Historic, 2004-2011
Table 9: Glucose Monitoring, New Zealand, Revenue ($m-) USD Constant, by Segment, Forecast, 2011-2018
Table 10: Blood Glucose Meters, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 11: Blood Glucose Meters, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 12: Glucose Monitoring, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 13: Glucose Monitoring, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 14: Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 15: Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 16: Glucose Monitoring, New Zealand, Average Price ($), Historic, 2004-2011
Table 17: Glucose Monitoring, New Zealand, Average Price ($), Forecast, 2011-2018
Table 18: Glucose Monitoring, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 19: Glucose Monitoring, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 20: Insulin Delivery Market, New Zealand, Segment Contribution (%), 2011
Table 21: Insulin Delivery, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 22: Insulin Delivery, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 23: Insulin Pens, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 24: Insulin Pens, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 25: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Revenue ($m) USD Constant, Historic, 2004-2011
Table 26: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Revenue ($m) USD Constant, Forecast, 2011-2018
Table 27: Insulin Delivery, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Table 28: Insulin Delivery, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Table 29: Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 30: Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 31: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Volume (Units), Historic, 2004-2011
Table 32: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Volume (Units), Forecast, 2011-2018
Table 33: Insulin Delivery, New Zealand, Average Price ($), Historic, 2004-2011
Table 34: Insulin Delivery, New Zealand, Average Price ($), Forecast, 2011-2018
Table 35: Insulin Delivery, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 36: Insulin Delivery, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 37: Diabetes Care Devices Market Pipeline Products

1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation
Figure 2: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: Diabetes Care Devices Market, New Zealand, Revenue Mix ($m), 2011
Figure 4: Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2011
Figure 5: Diabetes Care Devices, New Zealand, Cross-Segment Analysis, 2004-2018
Figure 6: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 7: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 8: Diabetes Care Devices, New Zealand, Company Share (%), 2011
Figure 9: Glucose Monitoring, Market Segmentation
Figure 10: Glucose Monitoring Market, New Zealand, Revenue Mix ($m), 2011
Figure 11: Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2011
Figure 12: Glucose Monitoring, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 13: Glucose Monitoring, New Zealand, Revenue ($m-) USD Constant, by Segment, Forecast, 2011-2018
Figure 14: Blood Glucose Meters, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 15: Blood Glucose Meters, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 16: Glucose Monitoring, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 17: Glucose Monitoring, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 18: Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 19: Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 20: Glucose Monitoring, New Zealand, Company Share (%), 2011
Figure 21: Insulin Delivery, Market Segmentation
Figure 22: Insulin Delivery Market, New Zealand, Revenue Mix ($m), 2011
Figure 23: Insulin Delivery Market, New Zealand, Segment Contribution (%), 2011
Figure 24: Insulin Delivery, New Zealand, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 25: Insulin Delivery, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 26: Insulin Pens, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 27: Insulin Pens, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 28: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Revenue ($m) USD Constant, Historic, 2004-2011
Figure 29 Insulin Pumps(Traditional Insulin Pumps), New Zealand, Revenue ($m) USD Constant, Forecast, 2011-2018
Figure 30: Insulin Delivery, New Zealand, Volume (Units) by Segment, Historic, 2004-2011
Figure 31: Insulin Delivery, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018
Figure 32: Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 33: Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 34: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Volume (Units), Historic, 2004-2011
Figure 35: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Volume (Units), Forecast, 2011-2018
Figure 36: Insulin Delivery, New Zealand, Company Share (%), 2011
Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),New Zealand Diabetes Care Devices Market, 2011
Figure 38: Abbott Laboratories, Company Share (%),New Zealand Diabetes Care Devices Market, 2011
Figure 39: Bayer HealthCare AG, Company Share (%),New Zealand Diabetes Care Devices Market, 2011
Figure 40: Novo Nordisk A/S, Company Share (%),New Zealand Diabetes Care Devices Market, 2011
Figure 41: ARKRAY, Inc., Company Share (%),New Zealand Diabetes Care Devices Market, 2011
Figure 42: Animas Corporation, Company Share (%),New Zealand Diabetes Care Devices Market, 2011

F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Bayer HealthCare AG
Novo Nordisk A/S
ARKRAY, Inc.
Animas Corporation
Eli Lilly and Company
LifeScan, Inc.
Medtronic, Inc.
Becton, Dickinson and Company
Sanofi
Terumo Corporation
Apex Biotechnology C

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos